Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Europe’s Pharma Industry Expects Little Relief In 2013 After Bruising 2012

Jan 14 2013

• By John Davis

Related Content

Value-Based Pricing's Slow Progress In U.K. Worries Industry

May 28 2012

GSK To Downplay Europe Because of Poor Innovation Support, Focuses On U.S. and Japan Instead

Feb 07 2012

Bayer Chief Worried About Innovation, Spanish Debts

Feb 28 2012

Sweden’s Reference Pricing Proposal: A Five-Year Doomsday Clock For Innovation?

Nov 06 2012

New German Reimbursement Process Splits Opinion Ahead Of First Assessments

Jul 25 2011

Related Companies

Eli Lilly and Company

GSK plc

Bayer AG

uniQure N.V.

Merck & Co., Inc.

Merck & Co., Inc.

Additional Topics

Europe Legislation Regulation Reimbursement Clinical Trials Business Strategies BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window